Verition Fund Management LLC Surface Oncology, Inc. Transaction History

Verition Fund Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.45 - $9.09 $2.36 Million - $3.32 Million	-365,575 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$7.25 - $13.82 $514,641 - $981,012	70,985 Added 24.1%	365,575 $2.85 Million
Q4 2020 Feb 16, 2021	BUY	$6.87 - $10.48 $452,842 - $690,799	65,916 Added 28.83%	294,590 $2.72 Million
Q3 2020 Nov 16, 2020	BUY	$5.06 - $7.23 $1.16 Million - $1.65 Million	228,674 New	228,674 $1.58 Million

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.